LIGANDAL | REGENERATIVE PEPTIDES
  • OVERVIEW
  • COVID-19
  • OUR SCIENCE
  • NEWSROOM
  • BOARD OF DIRECTORS
  • ADVISORY BOARD
  • CONTACT US

HUMAN T Cell EDITING CRISPR kit — Currently on hold

Picture
You will receive 10 doses of 48 unique formulations designed to deliver CRISPR-Cas9 ribonucleoproteins to human primary T cells. Mix the solutions with T cells in a 96-well plate or your preferred format, and CRISPR will edit them. It's that simple. Default gRNA targets TRAC locus. Not for human therapeutic use.
BUY NOW

    Want something else? send us MORE information.

    Max file size: 20MB
    Please specify up to 5 target cell types.
    Please provide details on relevant cell types, model organism, internal capabilities, and payload(s) of interest. E.g. Hematopoietic stem cells / T cells, CRISPR / mRNA, in vivo / ex vivo, mice, organoids, etc.
    E.g. joint ventures, licensing, publication
Submit
Ⓒ 2019 Ligandal Inc. All rights reserved.
  • OVERVIEW
  • COVID-19
  • OUR SCIENCE
  • NEWSROOM
  • BOARD OF DIRECTORS
  • ADVISORY BOARD
  • CONTACT US